Revision of reimbursement prices to support a stable supply of medical devices

Committee:
Medical Equipment
status:
Some progress
Published:
The FY2026 revision added a special provision to eliminate negative margins (reimbursement prices below purchase costs) for products in categories with mixed market shares. However, issues remain with regard to revising reimbursement prices in line with price levels and establishing a mechanism through which medical institutions can request the elimination of negative margins. An environment is needed that appropriately reflects increases in raw material, labor, logistics and other costs, enabling both suppliers and medical institutions to continue providing and using necessary products.

Recommendations

  • Establish reimbursement price revision rules that appropriately reflect changes in price levels and supply costs.
  • Verify the application record and effectiveness of the newly added special provision for eliminating negative margins, and review its scope and requirements as necessary.